News for WW International, Inc. (WW)

With renewed financial strength, WeightWatchers accelerates its transformation with the appointment of key executives including Dr. Kim Boyd as Chief Medical Officer

WeightWatchers Clinic Members Can Access FDA-Approved Wegovy® for $299 in July, a $200 Savings Offer to Improve Access as WeightWatchers’ Trusted, Science-Backed Approach Continues to Lead the Industry

WeightWatchers (WGHTQ) has announced its imminent emergence from a court-guided financial restructuring process, aiming to finalize this transition as early as

**media[657729]**

A simple oversight could end up costing Danish pharma giant Novo Nordisk A/S (NYSE: NVO) billions in potential losses on its blockbuster weight-loss and diabetes drug, Ozempic.

**media[633684]**

$1 billion diabetes startup Omada Health is launching new AI tools for nutrition care after filing its S-1 to go public.

When WW launched a new compounded semaglutide product late last year, the stock surged, renewing hopes of growth revival. Click to read why WW is a Strong Sell.

Key Takeaways: WW International (WW) has filed for Chapter 11 bankruptcy, citing challenges from GLP-1 medications and DIY weight-loss methods. Analysts

Read more about the factors that contributed to WW International's financial challenges.

Problems for the well-known brand began with the Coronavirus pandemic and continued as prescriptions gained favour

WW International Inc. filed for bankruptcy in an attempt to eliminate $1.15 billion in debt from its balance sheet, and position itself for long-term growth and success.

WW International sinks on Chapter 11 bankruptcy declaration. Stock futures rise on news of U.S.-China trade talks. Rivian unlocks an $1B investment from Volkswagen by recording gross profit.

Shares of Porch Group, Inc. PRCH rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results and ...

Once a dominant force in the weight-loss industry, WW International Inc. (NASDAQ: WW), formerly known as WeightWatchers, is feeling pressure from the disruptive rise of anti-obesity drugs, and is now staring at a bankruptcy process to reorganize its finances.

Shares of Twilio Inc. TWLO rose sharply in pre-market trading after the company reported better-than-expected first-quarter financial results. Twilio reported ...

Before the upcoming earnings announcement, Weight Watchers (WW) is experiencing increased options trading, with call options outnumbering put options by a ratio

US stock market today is swinging between gains and losses as investors react to Big Tech earnings and Trumps latest tariff news. The S&P 500, Dow Jones, and Nasdaq are all feeling the heat, while stocks like Apple, Microsoft, and Amazon—part of the Magnificent Seven—could shift market momentum. With futures wavering and sectors responding differently, traders are staying cautious. This is your one-stop update on top gainers, market trends, and whats moving Wall Street right now.

Summary: WeightWatchers' (WW) stock price skyrocketed by 132% before stabilizing at a 78.5% gain. The surge followed plans to offer Eli Lilly's Zepbound to m